A Phase 3 Randomized, Placebo-and Active Comparator Controlled, Clinical Trial to Study the Safety and Efficacy of Two Doses of Lurasidone HCl in Acutely Psychotic Patients With Schizophrenia.
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008666/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Lurasidone HCl is a compound developed for the treatment of schizophrenia. This clinical
study is designed to test the hypothesis that lurasidone is more efficacious than placebo.
The study will also evaluate the safety and tolerability of lurasidone as compared to
placebo.
提供机构：
Vivli
创建时间：
2022-12-15
